Want to join the conversation?
$VRTX said it received permission from EU to market ORKAMBI (lumacaftor/ivacaftor), a newly-developed medicinal product, which will serve patients in the management of cystic fibrosis in ages 12 & older with 2 copies of the F508del mutation. The study is based on a data collected from 24-week global Phase 3 studies, Traffic, Transport & Progress.
I haven’t seen a drop in banks like this in a long time. Looks like $WFC is still facing pressures from its sales practices scandal..!!
Helping President-elect's America first focus, $WMT set to create 10,000 retail jobs in the US in 2017.
Looks like Trump has his eyes on the $MON and Bayer merger next. He had a meeting with the CEOs and apparently got job promises from them.
$FHN shares have dropped after its earnings missed analysts’ expectations. I’m worried whether the stock will slide further.